Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL4916614

N.c1csc(CC2CC2)c1

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.47
MAPT P10636 1/20 0.47
TAAR1 Q96RJ0 1/20 0.43
KMT2A Q03164 4/20 0.43
POLB P06746 2/20 0.43
MEN1 O00255 3/20 0.41
HTT P42858 2/20 0.41
TSHR P16473 2/20 0.41
KDM4E B2RXH2 1/20 0.41
HRH3 Q9Y5N1 2/20 0.40
HPGD P15428 2/20 0.40
CYP2C19 P33261 1/20 0.38
ADRA2A P08913 1/20 0.38
ADRA2B P18089 1/20 0.38
ADRA2C P18825 1/20 0.38
KDM1A O60341 1/20 0.38
GAA P10253 1/20 0.38
GFER P55789 1/20 0.38
ALDH1A1 P00352 1/20 0.37
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1930288 0.98
SCHEMBL5364784 0.89 KMT2A (0.50) HSD17B10MAPTTAAR1KMT2APOLB
SCHEMBL13681486 0.88 HSD17B10 (0.46) HSD17B10MAPTTAAR1KMT2APOLB
SCHEMBL2375467 0.88 HPGD (0.51) HSD17B10MAPTTAAR1KMT2APOLB
SCHEMBL10722024 0.88 HPGD (0.51) HSD17B10MAPTTAAR1KMT2APOLB
SCHEMBL2679157 0.84 GBA1 (0.52) HSD17B10MAPTTAAR1KMT2APOLB
SCHEMBL8643295 0.84 HSD17B10 (0.41) HSD17B10MAPTTAAR1KMT2APOLB
SCHEMBL13681386 0.84 HSD17B10 (0.43) HSD17B10MAPTTAAR1KMT2APOLB
SCHEMBL8022303 0.79 HTT (0.42) HSD17B10MAPTTAAR1KMT2APOLB
Acetic Acid SCHEMBL9372583 0.77 HPGD (0.53) MAPTKMT2APOLBMEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080167500-A1 Process for the Preparation of a Diastereomerically Enriched Compound DSM IP ASSETS B.V. (NL) 2008-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080167500-A1 Process for the Preparation of a Diastereomerically Enriched Compound C1S, C1R, C9 HSD17B10 275/4885MAPT 4471/4885TAAR1 1735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.